| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.004 | 0.985 | Analgesic | 0.985 0.003 DB00327 0.98 0.004 DBMET00420 0.965 0.004 DBMET02686 0.965 0.004 DBMET02687 0.979 0.004 DBMET02685 0.979 0.004 DBMET02684 0.931 0.004 DBMET02723 0.908 0.004 DBMET02728 0.921 0.004 DBMET02726 0.93 0.004 DBMET02727 0.921 0.004 DBMET02724 0.93 0.004 DBMET02725 | DB00327 | |
| 0.957 | 0.002 | 0.969 | Psychostimulant | 0.958 0.002 DB00327 0.903 0.003 DBMET00420 0.917 0.003 DBMET02686 0.917 0.003 DBMET02687 0.917 0.003 DBMET02685 0.917 0.003 DBMET02684 0.969 0.002 DBMET02723 0.924 0.002 DBMET02728 0.939 0.002 DBMET02726 0.925 0.002 DBMET02727 0.939 0.002 DBMET02724 0.925 0.002 DBMET02725 | DBMET02723 | |
| 0.948 | 0.002 | 0.969 | Analgesic, opioid | 0.969 0.001 DB00327 0.926 0.002 DBMET00420 0.902 0.002 DBMET02686 0.902 0.002 DBMET02687 0.941 0.002 DBMET02685 0.941 0.002 DBMET02684 0.819 0.002 DBMET02723 0.782 0.002 DBMET02728 0.787 0.002 DBMET02726 0.823 0.002 DBMET02727 0.787 0.002 DBMET02724 0.823 0.002 DBMET02725 | DB00327 | |
| 0.894 | 0.001 | 0.926 | Opioid agonist | 0.926 0.001 DB00327 0.859 0.002 DBMET00420 0.809 0.002 DBMET02686 0.809 0.002 DBMET02687 0.867 0.002 DBMET02685 0.867 0.002 DBMET02684 0.765 0.002 DBMET02723 0.702 0.003 DBMET02728 0.719 0.003 DBMET02726 0.749 0.002 DBMET02727 0.719 0.003 DBMET02724 0.749 0.002 DBMET02725 | DB00327 | |
| 0.876 | 0.001 | 0.906 | Opioid mu receptor agonist | 0.906 0.001 DB00327 0.824 0.001 DBMET00420 0.767 0.002 DBMET02686 0.767 0.002 DBMET02687 0.835 0.001 DBMET02685 0.835 0.001 DBMET02684 0.718 0.002 DBMET02723 0.647 0.002 DBMET02728 0.67 0.002 DBMET02726 0.688 0.002 DBMET02727 0.67 0.002 DBMET02724 0.688 0.002 DBMET02725 | DB00327 | |
| 0.87 | 0.001 | 0.905 | Opioid antagonist | 0.905 0.001 DB00327 0.853 0.002 DBMET00420 0.834 0.002 DBMET02686 0.834 0.002 DBMET02687 0.86 0.002 DBMET02685 0.86 0.002 DBMET02684 0.8 0.002 DBMET02723 0.755 0.003 DBMET02728 0.767 0.003 DBMET02726 0.792 0.002 DBMET02727 0.767 0.003 DBMET02724 0.792 0.002 DBMET02725 | DB00327 | |
| 0.856 | 0.001 | 0.902 | Opioid mu receptor antagonist | 0.902 0.001 DB00327 0.833 0.001 DBMET00420 0.808 0.002 DBMET02686 0.808 0.002 DBMET02687 0.844 0.001 DBMET02685 0.844 0.001 DBMET02684 0.766 0.002 DBMET02723 0.722 0.002 DBMET02728 0.728 0.002 DBMET02726 0.765 0.002 DBMET02727 0.728 0.002 DBMET02724 0.765 0.002 DBMET02725 | DB00327 | |
| 0.804 | 0.002 | 0.85 | Opioid delta receptor agonist | 0.85 0.001 DB00327 0.764 0.002 DBMET00420 0.668 0.002 DBMET02686 0.668 0.002 DBMET02687 0.738 0.002 DBMET02685 0.738 0.002 DBMET02684 0.64 0.002 DBMET02723 0.477 0.003 DBMET02728 0.526 0.003 DBMET02726 0.576 0.003 DBMET02727 0.526 0.003 DBMET02724 0.576 0.003 DBMET02725 | DB00327 | |
| 0.803 | 0.001 | 0.848 | Opioid delta receptor antagonist | 0.848 0.001 DB00327 0.786 0.002 DBMET00420 0.763 0.002 DBMET02686 0.763 0.002 DBMET02687 0.789 0.002 DBMET02685 0.789 0.002 DBMET02684 0.734 0.002 DBMET02723 0.655 0.003 DBMET02728 0.677 0.003 DBMET02726 0.714 0.002 DBMET02727 0.677 0.003 DBMET02724 0.714 0.002 DBMET02725 | DB00327 | |
| 0.784 | 0.001 | 0.818 | Opioid kappa receptor antagonist | 0.818 0.001 DB00327 0.765 0.001 DBMET00420 0.746 0.002 DBMET02686 0.746 0.002 DBMET02687 0.773 0.001 DBMET02685 0.773 0.001 DBMET02684 0.691 0.002 DBMET02723 0.628 0.002 DBMET02728 0.644 0.002 DBMET02726 0.674 0.002 DBMET02727 0.644 0.002 DBMET02724 0.674 0.002 DBMET02725 | DB00327 | |
| 0.742 | 0.003 | 0.764 | Sigma receptor antagonist | 0.764 0.003 DB00327 0.694 0.004 DBMET00420 0.556 0.004 DBMET02686 0.556 0.004 DBMET02687 0.645 0.004 DBMET02685 0.645 0.004 DBMET02684 0.273 0.007 DBMET02723 0.116 0.014 DBMET02728 0.139 0.012 DBMET02726 0.164 0.01 DBMET02727 0.139 0.012 DBMET02724 0.164 0.01 DBMET02725 | DB00327 | |
| 0.703 | 0.003 | 0.797 | Anesthetic general | 0.754 0.003 DB00327 0.559 0.005 DBMET00420 0.762 0.003 DBMET02686 0.762 0.003 DBMET02687 0.777 0.003 DBMET02685 0.777 0.003 DBMET02684 0.67 0.004 DBMET02723 0.783 0.003 DBMET02728 0.666 0.004 DBMET02726 0.797 0.003 DBMET02727 0.666 0.004 DBMET02724 0.797 0.003 DBMET02725 | DBMET02725 | |
| 0.704 | 0.007 | 0.74 | 5 Hydroxytryptamine release stimulant | 0.704 0.007 DB00327 0.531 0.023 DBMET00420 0.731 0.005 DBMET02686 0.731 0.005 DBMET02687 0.736 0.005 DBMET02685 0.736 0.005 DBMET02684 0.619 0.013 DBMET02723 0.735 0.005 DBMET02728 0.671 0.009 DBMET02726 0.74 0.005 DBMET02727 0.671 0.009 DBMET02724 0.74 0.005 DBMET02725 | DBMET02725 | |
| 0.696 | 0.001 | 0.729 | Opioid kappa receptor agonist | 0.729 0.001 DB00327 0.647 0.001 DBMET00420 0.602 0.001 DBMET02686 0.602 0.001 DBMET02687 0.661 0.001 DBMET02685 0.661 0.001 DBMET02684 0.523 0.002 DBMET02723 0.415 0.002 DBMET02728 0.453 0.002 DBMET02726 0.471 0.002 DBMET02727 0.453 0.002 DBMET02724 0.471 0.002 DBMET02725 | DB00327 | |
| 0.653 | 0.003 | 0.656 | Sigma receptor agonist | 0.646 0.004 DB00327 0.528 0.007 DBMET00420 0.652 0.003 DBMET02686 0.652 0.003 DBMET02687 0.656 0.003 DBMET02685 0.656 0.003 DBMET02684 0.531 0.007 DBMET02723 0.548 0.006 DBMET02728 0.551 0.006 DBMET02726 0.547 0.006 DBMET02727 0.551 0.006 DBMET02724 0.547 0.006 DBMET02725 | DBMET02684 | |
| 0.617 | 0.003 | 0.62 | Toll-Like receptor antagonist | 0.62 0.003 DB00327 0.564 0.003 DBMET00420 0.41 0.004 DBMET02686 0.41 0.004 DBMET02687 0.431 0.004 DBMET02685 0.431 0.004 DBMET02684 0.273 0.01 DBMET02723 0.209 0.028 DBMET02728 0.156 0.052 DBMET02726 0.226 0.022 DBMET02727 0.156 0.052 DBMET02724 0.226 0.022 DBMET02725 | DB00327 | |
| 0.59 | 0.014 | 0.872 | Spasmolytic | 0.629 0.01 DB00327 0.446 0.032 DBMET00420 0.84 0.004 DBMET02686 0.84 0.004 DBMET02687 0.855 0.004 DBMET02685 0.855 0.004 DBMET02684 0.673 0.008 DBMET02723 0.826 0.004 DBMET02728 0.872 0.004 DBMET02726 0.842 0.004 DBMET02727 0.872 0.004 DBMET02724 0.842 0.004 DBMET02725 | DBMET02724 | |
| 0.551 | 0.001 | 0.565 | Toll-Like receptor 4 antagonist | 0.565 0.001 DB00327 0.548 0.001 DBMET00420 0.414 0.002 DBMET02686 0.414 0.002 DBMET02687 0.442 0.002 DBMET02685 0.442 0.002 DBMET02684 0.497 0.002 DBMET02723 0.368 0.003 DBMET02728 0.379 0.003 DBMET02726 0.403 0.003 DBMET02727 0.379 0.003 DBMET02724 0.403 0.003 DBMET02725 | DB00327 | |
| 0.528 | 0.004 | 0.619 | Antipruritic | 0.602 0.004 DB00327 0.504 0.004 DBMET00420 0.543 0.004 DBMET02686 0.543 0.004 DBMET02687 0.619 0.004 DBMET02685 0.619 0.004 DBMET02684 0.332 0.01 DBMET02723 0.285 0.017 DBMET02728 0.329 0.01 DBMET02726 0.331 0.01 DBMET02727 0.329 0.01 DBMET02724 0.331 0.01 DBMET02725 | DBMET02684 | |
| 0.534 | 0.039 | 0.859 | Transcription factor NF kappa B inhibitor | 0.582 0.033 DB00327 0.497 0.045 DBMET00420 0.521 0.041 DBMET02686 0.521 0.041 DBMET02687 0.519 0.041 DBMET02685 0.519 0.041 DBMET02684 0.859 0.009 DBMET02723 0.735 0.017 DBMET02728 0.789 0.014 DBMET02726 0.733 0.017 DBMET02727 0.789 0.014 DBMET02724 0.733 0.017 DBMET02725 | DBMET02723 | |
| 0.427 | 0.005 | 0.591 | Alpha 2 adrenoreceptor antagonist | 0.341 0.006 DB00327 0.408 0.005 DBMET00420 0.591 0.004 DBMET02686 0.591 0.004 DBMET02687 0.561 0.004 DBMET02685 0.561 0.004 DBMET02684 0.108 0.043 DBMET02728 0.098 0.049 DBMET02727 0.098 0.049 DBMET02725 | DBMET02687 | |
| 0.415 | 0.009 | 0.426 | Cholinergic | 0.338 0.014 DB00327 0.426 0.009 DBMET00420 0.309 0.018 DBMET02686 0.309 0.018 DBMET02687 0.277 0.022 DBMET02685 0.277 0.022 DBMET02684 0.159 0.07 DBMET02723 0.13 0.096 DBMET02728 0.127 0.099 DBMET02726 0.127 0.099 DBMET02724 | DBMET00420 | |
| 0.419 | 0.014 | 0.419 | P-glycoprotein inhibitor | 0.336 0.023 DB00327 0.327 0.024 DBMET00420 0.349 0.021 DBMET02686 0.349 0.021 DBMET02687 0.283 0.032 DBMET02685 0.283 0.032 DBMET02684 0.272 0.035 DBMET02723 0.29 0.031 DBMET02728 0.231 0.048 DBMET02726 0.246 0.043 DBMET02727 0.231 0.048 DBMET02724 0.246 0.043 DBMET02725 | ||
| 0.369 | 0.007 | 0.482 | Acetylcholine M1 receptor antagonist | 0.482 0.004 DB00327 0.273 0.02 DBMET00420 0.366 0.007 DBMET02686 0.366 0.007 DBMET02687 0.478 0.004 DBMET02685 0.478 0.004 DBMET02684 0.171 0.058 DBMET02723 0.117 0.113 DBMET02728 0.163 0.063 DBMET02726 0.175 0.055 DBMET02727 0.163 0.063 DBMET02724 0.175 0.055 DBMET02725 | DB00327 | |
| 0.351 | 0.005 | 0.552 | Alpha 2a adrenoreceptor antagonist | 0.379 0.005 DB00327 0.343 0.005 DBMET00420 0.486 0.004 DBMET02686 0.486 0.004 DBMET02687 0.552 0.004 DBMET02685 0.552 0.004 DBMET02684 0.072 0.056 DBMET02728 0.091 0.041 DBMET02727 0.091 0.041 DBMET02725 | DBMET02684 | |
| 0.366 | 0.021 | 0.395 | 5 Hydroxytryptamine uptake stimulant | 0.336 0.03 DB00327 0.395 0.015 DBMET00420 0.352 0.025 DBMET02686 0.352 0.025 DBMET02687 0.322 0.035 DBMET02685 0.322 0.035 DBMET02684 | DBMET00420 | |
| 0.397 | 0.056 | 0.466 | Vasodilator, peripheral | 0.318 0.088 DB00327 0.219 0.155 DBMET00420 0.466 0.036 DBMET02686 0.466 0.036 DBMET02687 0.362 0.069 DBMET02685 0.362 0.069 DBMET02684 0.313 0.09 DBMET02723 0.459 0.038 DBMET02728 0.292 0.101 DBMET02726 0.353 0.072 DBMET02727 0.292 0.101 DBMET02724 0.353 0.072 DBMET02725 | DBMET02687 | |
| 0.349 | 0.012 | 0.386 | Alpha adrenoreceptor antagonist | 0.171 0.032 DB00327 0.283 0.017 DBMET00420 0.386 0.01 DBMET02686 0.386 0.01 DBMET02687 0.245 0.021 DBMET02685 0.245 0.021 DBMET02684 | DBMET02687 | |
| 0.334 | 0.012 | 0.4 | Cholinergic antagonist | 0.385 0.008 DB00327 0.256 0.02 DBMET00420 0.333 0.012 DBMET02686 0.333 0.012 DBMET02687 0.4 0.008 DBMET02685 0.4 0.008 DBMET02684 0.111 0.082 DBMET02727 0.111 0.082 DBMET02725 | DBMET02684 | |
| 0.324 | 0.012 | 0.39 | Acetylcholine antagonist | 0.375 0.009 DB00327 0.252 0.02 DBMET00420 0.322 0.012 DBMET02686 0.322 0.012 DBMET02687 0.39 0.008 DBMET02685 0.39 0.008 DBMET02684 | DBMET02684 | |
| 0.322 | 0.011 | 0.322 | Acetylcholinesterase inhibitor | 0.263 0.018 DB00327 0.265 0.018 DBMET00420 0.237 0.023 DBMET02686 0.237 0.023 DBMET02687 0.201 0.033 DBMET02685 0.201 0.033 DBMET02684 0.132 0.068 DBMET02723 0.106 0.095 DBMET02728 | ||
| 0.318 | 0.037 | 0.473 | Nitric oxide antagonist | 0.33 0.035 DB00327 0.289 0.043 DBMET00420 0.338 0.034 DBMET02686 0.338 0.034 DBMET02687 0.343 0.033 DBMET02685 0.343 0.033 DBMET02684 0.473 0.018 DBMET02723 0.414 0.024 DBMET02728 0.47 0.018 DBMET02726 0.42 0.023 DBMET02727 0.47 0.018 DBMET02724 0.42 0.023 DBMET02725 | DBMET02723 | |
| 0.231 | 0.011 | 0.251 | Breast cancer-resistant protein inhibitor | 0.18 0.016 DB00327 0.251 0.009 DBMET00420 0.184 0.016 DBMET02686 0.184 0.016 DBMET02687 0.155 0.022 DBMET02685 0.155 0.022 DBMET02684 | DBMET00420 | |
| 0.227 | 0.01 | 0.235 | Acetylcholine nicotinic antagonist | 0.199 0.013 DB00327 0.192 0.013 DBMET00420 0.22 0.011 DBMET02686 0.22 0.011 DBMET02687 0.235 0.01 DBMET02685 0.235 0.01 DBMET02684 | DBMET02684 | |
| 0.222 | 0.008 | 0.262 | Dopamine agonist | 0.262 0.006 DB00327 0.198 0.01 DBMET00420 0.202 0.01 DBMET02686 0.202 0.01 DBMET02687 0.251 0.007 DBMET02685 0.251 0.007 DBMET02684 0.093 0.03 DBMET02723 0.088 0.032 DBMET02728 0.099 0.028 DBMET02726 0.106 0.025 DBMET02727 0.099 0.028 DBMET02724 0.106 0.025 DBMET02725 | DB00327 | |
| 0.306 | 0.111 | 0.517 | Immunosuppressant | 0.357 0.083 DB00327 0.362 0.08 DBMET00420 0.423 0.055 DBMET02686 0.423 0.055 DBMET02687 0.452 0.046 DBMET02685 0.452 0.046 DBMET02684 0.488 0.036 DBMET02723 0.49 0.036 DBMET02728 0.517 0.029 DBMET02726 0.506 0.031 DBMET02727 0.517 0.029 DBMET02724 0.506 0.031 DBMET02725 | DBMET02724 | |
| 0.209 | 0.022 | 0.265 | Acetylcholine muscarinic antagonist | 0.256 0.014 DB00327 0.136 0.053 DBMET00420 0.217 0.02 DBMET02686 0.217 0.02 DBMET02687 0.265 0.012 DBMET02685 0.265 0.012 DBMET02684 | DBMET02684 | |
| 0.203 | 0.017 | 0.213 | Alpha 2c adrenoreceptor antagonist | 0.129 0.044 DB00327 0.159 0.029 DBMET00420 0.213 0.015 DBMET02686 0.213 0.015 DBMET02687 0.155 0.03 DBMET02685 0.155 0.03 DBMET02684 | DBMET02687 | |
| 0.186 | 0.005 | 0.238 | Dopamine D2 agonist | 0.238 0.005 DB00327 0.064 0.019 DBMET00420 0.164 0.006 DBMET02686 0.164 0.006 DBMET02687 0.219 0.005 DBMET02685 0.219 0.005 DBMET02684 0.126 0.008 DBMET02723 0.103 0.01 DBMET02728 0.13 0.008 DBMET02726 0.128 0.008 DBMET02727 0.13 0.008 DBMET02724 0.128 0.008 DBMET02725 | DB00327 | |
| 0.219 | 0.045 | 0.239 | Lipocortins synthesis antagonist | 0.239 0.037 DB00327 0.208 0.052 DBMET00420 0.211 0.05 DBMET02686 0.211 0.05 DBMET02687 0.217 0.047 DBMET02685 0.217 0.047 DBMET02684 0.207 0.052 DBMET02723 0.163 0.088 DBMET02728 0.171 0.079 DBMET02726 0.166 0.085 DBMET02727 0.171 0.079 DBMET02724 0.166 0.085 DBMET02725 | DB00327 | |
| 0.193 | 0.021 | 0.434 | Cyclooxygenase 3 inhibitor | 0.17 0.033 DB00327 0.227 0.012 DBMET00420 0.175 0.03 DBMET02686 0.175 0.03 DBMET02687 0.148 0.049 DBMET02685 0.148 0.049 DBMET02684 0.434 0.004 DBMET02723 0.324 0.005 DBMET02728 0.338 0.005 DBMET02726 0.26 0.008 DBMET02727 0.338 0.005 DBMET02724 0.26 0.008 DBMET02725 | DBMET02723 | |
| 0.179 | 0.013 | 0.252 | Prolactin inhibitor | 0.233 0.005 DB00327 0.156 0.02 DBMET00420 0.212 0.007 DBMET02686 0.212 0.007 DBMET02687 0.252 0.004 DBMET02685 0.252 0.004 DBMET02684 | DBMET02684 | |
| 0.166 | 0.011 | 0.166 | Neuronal nicotinic receptor antagonist | 0.142 0.013 DB00327 0.143 0.013 DBMET00420 0.144 0.013 DBMET02686 0.144 0.013 DBMET02687 0.157 0.012 DBMET02685 0.157 0.012 DBMET02684 | ||
| 0.175 | 0.022 | 0.175 | Dopamine antagonist | 0.128 0.03 DB00327 0.096 0.04 DBMET00420 0.108 0.035 DBMET02686 0.108 0.035 DBMET02687 0.093 0.041 DBMET02685 0.093 0.041 DBMET02684 | ||
| 0.209 | 0.06 | 0.448 | Hepatoprotectant | 0.211 0.059 DB00327 0.181 0.079 DBMET00420 0.304 0.028 DBMET02686 0.304 0.028 DBMET02687 0.302 0.029 DBMET02685 0.302 0.029 DBMET02684 0.39 0.014 DBMET02723 0.406 0.013 DBMET02728 0.448 0.01 DBMET02726 0.409 0.012 DBMET02727 0.448 0.01 DBMET02724 0.409 0.012 DBMET02725 | DBMET02724 | |
| 0.168 | 0.026 | 0.168 | Alpha 1 adrenoreceptor antagonist | 0.092 0.047 DBMET00420 0.12 0.037 DBMET02686 0.12 0.037 DBMET02687 | ||
| 0.164 | 0.024 | 0.187 | Antineoplastic alkaloid | 0.183 0.019 DB00327 0.132 0.033 DBMET00420 0.183 0.018 DBMET02686 0.183 0.018 DBMET02687 0.187 0.017 DBMET02685 0.187 0.017 DBMET02684 0.092 0.053 DBMET02723 0.089 0.056 DBMET02728 0.086 0.058 DBMET02726 0.088 0.056 DBMET02727 0.086 0.058 DBMET02724 0.088 0.056 DBMET02725 | DBMET02684 | |
| 0.167 | 0.027 | 0.197 | Nav1.1 sodium channel blocker | 0.179 0.024 DB00327 0.18 0.023 DBMET02686 0.18 0.023 DBMET02687 0.197 0.019 DBMET02685 0.197 0.019 DBMET02684 | DBMET02684 | |
| 0.159 | 0.022 | 0.159 | Alpha 1a adrenoreceptor antagonist | 0.096 0.038 DBMET00420 0.116 0.03 DBMET02686 0.116 0.03 DBMET02687 | ||
| 0.249 | 0.113 | 0.356 | Caspase 3 stimulant | 0.233 0.128 DB00327 0.196 0.175 DBMET00420 0.295 0.081 DBMET02686 0.295 0.081 DBMET02687 0.266 0.099 DBMET02685 0.266 0.099 DBMET02684 0.235 0.126 DBMET02723 0.356 0.057 DBMET02728 0.247 0.115 DBMET02726 0.333 0.065 DBMET02727 0.247 0.115 DBMET02724 0.333 0.065 DBMET02725 | DBMET02728 | |
| 0.144 | 0.011 | 0.144 | Alpha 2d adrenoreceptor antagonist | 0.136 0.014 DB00327 0.143 0.011 DBMET00420 0.14 0.012 DBMET02686 0.14 0.012 DBMET02687 0.138 0.013 DBMET02685 0.138 0.013 DBMET02684 0.093 0.063 DBMET02723 0.101 0.047 DBMET02728 0.098 0.053 DBMET02726 0.096 0.055 DBMET02727 0.098 0.053 DBMET02724 0.096 0.055 DBMET02725 | ||
| 0.15 | 0.02 | 0.16 | Acetylcholine M3 receptor agonist | 0.141 0.024 DB00327 0.149 0.02 DBMET00420 0.157 0.016 DBMET02686 0.157 0.016 DBMET02687 0.16 0.015 DBMET02685 0.16 0.015 DBMET02684 0.082 0.058 DBMET02728 0.088 0.053 DBMET02726 0.084 0.057 DBMET02727 0.088 0.053 DBMET02724 0.084 0.057 DBMET02725 | DBMET02684 | |
| 0.323 | 0.194 | 0.741 | Antiinflammatory | 0.366 0.161 DB00327 0.298 0.218 DBMET00420 0.459 0.106 DBMET02686 0.459 0.106 DBMET02687 0.476 0.098 DBMET02685 0.476 0.098 DBMET02684 0.718 0.028 DBMET02723 0.648 0.041 DBMET02728 0.741 0.024 DBMET02726 0.663 0.038 DBMET02727 0.741 0.024 DBMET02724 0.663 0.038 DBMET02725 | DBMET02724 | |
| 0.131 | 0.003 | 0.136 | Prolactin release inhibitor | 0.134 0.003 DB00327 0.1 0.004 DBMET00420 0.129 0.003 DBMET02686 0.129 0.003 DBMET02687 0.136 0.003 DBMET02685 0.136 0.003 DBMET02684 0.102 0.004 DBMET02723 0.099 0.005 DBMET02728 0.103 0.004 DBMET02726 0.103 0.004 DBMET02727 0.103 0.004 DBMET02724 0.103 0.004 DBMET02725 | DBMET02684 | |
| 0.174 | 0.048 | 0.213 | Toll-Like receptor 9 antagonist | 0.163 0.055 DB00327 0.213 0.03 DBMET00420 | DBMET00420 | |
| 0.156 | 0.034 | 0.197 | Antiadrenergic | 0.106 0.052 DB00327 0.156 0.034 DBMET00420 0.197 0.025 DBMET02686 0.197 0.025 DBMET02687 0.161 0.033 DBMET02685 0.161 0.033 DBMET02684 | DBMET02687 | |
| 0.154 | 0.037 | 0.154 | Alpha 2b adrenoreceptor antagonist | 0.096 0.079 DB00327 0.134 0.048 DBMET00420 0.154 0.037 DBMET02686 0.154 0.037 DBMET02687 0.118 0.06 DBMET02685 0.118 0.06 DBMET02684 | ||
| 0.148 | 0.035 | 0.162 | Adrenaline antagonist | 0.098 0.055 DB00327 0.148 0.035 DBMET00420 0.162 0.031 DBMET02686 0.162 0.031 DBMET02687 0.122 0.043 DBMET02685 0.122 0.043 DBMET02684 | DBMET02687 | |
| 0.206 | 0.104 | 0.382 | Tumour necrosis factor alpha release inhibitor | 0.281 0.061 DBMET02686 0.281 0.061 DBMET02687 0.292 0.057 DBMET02723 0.382 0.03 DBMET02728 0.334 0.042 DBMET02726 0.296 0.055 DBMET02727 0.334 0.042 DBMET02724 0.296 0.055 DBMET02725 | DBMET02728 | |
| 0.225 | 0.123 | 0.359 | Hypoxia-inducible factor 1 alpha inhibitor | 0.25 0.1 DB00327 0.311 0.06 DBMET02686 0.311 0.06 DBMET02687 0.306 0.063 DBMET02685 0.306 0.063 DBMET02684 0.237 0.112 DBMET02723 0.359 0.042 DBMET02728 0.269 0.084 DBMET02726 0.353 0.044 DBMET02727 0.269 0.084 DBMET02724 0.353 0.044 DBMET02725 | DBMET02728 | |
| 0.129 | 0.036 | 0.129 | Electron transport complex I inhibitor | 0.116 0.053 DB00327 0.119 0.049 DBMET00420 0.12 0.047 DBMET02686 0.12 0.047 DBMET02687 0.107 0.068 DBMET02685 0.107 0.068 DBMET02684 | ||
| 0.133 | 0.043 | 0.63 | Expectorant | 0.116 0.053 DB00327 0.114 0.055 DBMET00420 0.277 0.01 DBMET02686 0.277 0.01 DBMET02687 0.212 0.018 DBMET02685 0.212 0.018 DBMET02684 0.354 0.006 DBMET02723 0.63 0.003 DBMET02728 0.519 0.003 DBMET02726 0.531 0.003 DBMET02727 0.519 0.003 DBMET02724 0.531 0.003 DBMET02725 | DBMET02728 | |
| 0.097 | 0.009 | 0.134 | Dopamine D5 antagonist | 0.134 0.007 DB00327 0.067 0.016 DBMET00420 0.086 0.011 DBMET02686 0.086 0.011 DBMET02687 0.12 0.008 DBMET02685 0.12 0.008 DBMET02684 | DB00327 | |
| 0.159 | 0.077 | 0.254 | Interleukin 6 antagonist | 0.174 0.06 DB00327 0.196 0.043 DBMET02686 0.196 0.043 DBMET02687 0.204 0.038 DBMET02685 0.204 0.038 DBMET02684 0.219 0.031 DBMET02723 0.242 0.025 DBMET02728 0.236 0.026 DBMET02726 0.254 0.022 DBMET02727 0.236 0.026 DBMET02724 0.254 0.022 DBMET02725 | DBMET02725 | |
| 0.238 | 0.162 | 0.286 | Calcium channel activator | 0.262 0.133 DBMET00420 0.286 0.106 DBMET02686 0.286 0.106 DBMET02687 0.241 0.158 DBMET02685 0.241 0.158 DBMET02684 | DBMET02687 | |
| 0.105 | 0.031 | 0.105 | Dopamine D2 antagonist | 0.071 0.043 DB00327 0.055 0.053 DBMET00420 0.104 0.031 DBMET02686 0.104 0.031 DBMET02687 0.086 0.037 DBMET02685 0.086 0.037 DBMET02684 | ||
| 0.112 | 0.04 | 0.112 | Acetylcholine agonist | 0.08 0.066 DB00327 0.109 0.041 DBMET00420 0.104 0.044 DBMET02686 0.104 0.044 DBMET02687 0.104 0.044 DBMET02685 0.104 0.044 DBMET02684 | ||
| 0.125 | 0.056 | 0.125 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.075 | 0.008 | 0.115 | Nociceptin (N/OFQ) receptor antagonist | 0.112 0.005 DB00327 0.053 0.013 DBMET00420 0.068 0.009 DBMET02686 0.068 0.009 DBMET02687 0.115 0.005 DBMET02685 0.115 0.005 DBMET02684 | DBMET02684 | |
| 0.135 | 0.068 | 0.155 | Nav1.2 sodium channel blocker | 0.105 0.104 DB00327 0.155 0.054 DBMET02686 0.155 0.054 DBMET02687 0.138 0.065 DBMET02685 0.138 0.065 DBMET02684 | DBMET02687 | |
| 0.08 | 0.017 | 0.08 | Nicotinic receptor alpha7 subunit antagonist | 0.064 0.025 DB00327 0.076 0.019 DBMET00420 0.063 0.026 DBMET02686 0.063 0.026 DBMET02687 0.065 0.024 DBMET02685 0.065 0.024 DBMET02684 | ||
| 0.065 | 0.003 | 0.083 | NMDA receptor phencyclidine site antagonist | 0.072 0.003 DB00327 0.083 0.002 DBMET00420 0.06 0.003 DBMET02686 0.06 0.003 DBMET02687 0.071 0.003 DBMET02685 0.071 0.003 DBMET02684 | DBMET00420 | |
| 0.138 | 0.077 | 0.293 | Protein kinase stimulant | 0.162 0.06 DB00327 0.132 0.082 DBMET00420 0.177 0.052 DBMET02686 0.177 0.052 DBMET02687 0.176 0.052 DBMET02685 0.176 0.052 DBMET02684 0.293 0.018 DBMET02723 0.269 0.022 DBMET02728 0.276 0.02 DBMET02726 0.269 0.022 DBMET02727 0.276 0.02 DBMET02724 0.269 0.022 DBMET02725 | DBMET02723 | |
| 0.088 | 0.029 | 0.168 | Dopamine D1 antagonist | 0.168 0.013 DB00327 0.089 0.029 DBMET02686 0.089 0.029 DBMET02687 0.138 0.017 DBMET02685 0.138 0.017 DBMET02684 | DB00327 | |
| 0.086 | 0.027 | 0.086 | Orexin receptor 1 antagonist | 0.077 0.039 DBMET02686 0.077 0.039 DBMET02687 | ||
| 0.061 | 0.012 | 0.098 | Nicotinic receptor beta4 subunit antagonist | 0.064 0.011 DB00327 0.098 0.006 DBMET00420 0.057 0.013 DBMET02686 0.057 0.013 DBMET02687 0.063 0.011 DBMET02685 0.063 0.011 DBMET02684 | DBMET00420 | |
| 0.27 | 0.229 | 0.404 | Caspase 9 stimulant | 0.258 0.244 DBMET00420 0.343 0.151 DBMET02686 0.343 0.151 DBMET02687 0.302 0.192 DBMET02685 0.302 0.192 DBMET02684 0.261 0.239 DBMET02723 0.404 0.109 DBMET02728 0.285 0.211 DBMET02726 0.355 0.142 DBMET02727 0.285 0.211 DBMET02724 0.355 0.142 DBMET02725 | DBMET02728 | |
| 0.161 | 0.122 | 0.193 | Neurotrophic factor enhancer | 0.183 0.094 DB00327 0.153 0.134 DBMET00420 0.185 0.092 DBMET02686 0.185 0.092 DBMET02687 0.186 0.091 DBMET02685 0.186 0.091 DBMET02684 0.193 0.083 DBMET02723 0.163 0.119 DBMET02728 0.187 0.09 DBMET02726 0.165 0.117 DBMET02727 0.187 0.09 DBMET02724 0.165 0.117 DBMET02725 | DBMET02723 | |
| 0.064 | 0.025 | 0.069 | Acetylcholine M2 receptor agonist | 0.06 0.029 DB00327 0.056 0.034 DBMET00420 0.068 0.021 DBMET02686 0.068 0.021 DBMET02687 0.069 0.02 DBMET02685 0.069 0.02 DBMET02684 | DBMET02684 | |
| 0.073 | 0.035 | 0.073 | Orexin receptor antagonist | 0.063 0.051 DBMET02686 0.063 0.051 DBMET02687 | ||
| 0.068 | 0.031 | 0.093 | Dopamine uptake inhibitor | 0.051 0.048 DB00327 0.093 0.02 DBMET02686 0.093 0.02 DBMET02687 0.078 0.026 DBMET02685 0.078 0.026 DBMET02684 | DBMET02687 | |
| 0.1 | 0.065 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 DB00327 0.096 0.072 DBMET00420 0.102 0.061 DBMET02686 0.102 0.061 DBMET02687 0.111 0.045 DBMET02685 0.111 0.045 DBMET02684 | DB00327 | |
| 0.09 | 0.056 | 0.09 | Calcium antagonist | |||
| 0.167 | 0.134 | 0.343 | Vasodilator | 0.16 0.143 DB00327 0.167 0.135 DBMET00420 0.277 0.057 DBMET02686 0.277 0.057 DBMET02687 0.264 0.062 DBMET02685 0.264 0.062 DBMET02684 0.277 0.056 DBMET02723 0.31 0.045 DBMET02728 0.343 0.035 DBMET02726 0.302 0.047 DBMET02727 0.343 0.035 DBMET02724 0.302 0.047 DBMET02725 | DBMET02724 | |
| 0.13 | 0.097 | 0.434 | NOS3 expression enhancer | 0.167 0.058 DB00327 0.141 0.082 DBMET02686 0.141 0.082 DBMET02687 0.168 0.057 DBMET02685 0.168 0.057 DBMET02684 0.434 0.007 DBMET02723 0.228 0.032 DBMET02728 0.425 0.007 DBMET02726 0.263 0.024 DBMET02727 0.425 0.007 DBMET02724 0.263 0.024 DBMET02725 | DBMET02723 | |
| 0.038 | 0.006 | 0.065 | Dopamine D1 agonist | 0.055 0.004 DB00327 0.065 0.004 DBMET00420 0.037 0.006 DBMET02686 0.037 0.006 DBMET02687 0.053 0.004 DBMET02685 0.053 0.004 DBMET02684 0.046 0.005 DBMET02723 0.036 0.006 DBMET02728 0.046 0.005 DBMET02726 0.047 0.005 DBMET02727 0.046 0.005 DBMET02724 0.047 0.005 DBMET02725 | DBMET00420 | |
| 0.055 | 0.026 | 0.111 | Nicotinic receptor alpha4 subunit antagonist | 0.056 0.025 DB00327 0.111 0.007 DBMET00420 0.05 0.032 DBMET02686 0.05 0.032 DBMET02687 0.056 0.025 DBMET02685 0.056 0.025 DBMET02684 | DBMET00420 | |
| 0.107 | 0.081 | 0.129 | Estrogen antagonist | 0.129 0.04 DB00327 0.108 0.079 DBMET00420 0.115 0.065 DBMET02686 0.115 0.065 DBMET02687 0.124 0.049 DBMET02685 0.124 0.049 DBMET02684 | DB00327 | |
| 0.186 | 0.163 | 0.236 | Tyrosine 3 hydroxylase inhibitor | 0.236 0.082 DB00327 0.2 0.135 DBMET00420 0.2 0.136 DBMET02685 0.2 0.136 DBMET02684 | DB00327 | |
| 0.051 | 0.032 | 0.057 | Dopamine transporter inhibitor | 0.043 0.04 DB00327 0.057 0.027 DBMET02686 0.057 0.027 DBMET02687 0.055 0.028 DBMET02685 0.055 0.028 DBMET02684 | DBMET02687 | |
| 0.06 | 0.044 | 0.064 | Adrenaline uptake inhibitor | 0.064 0.04 DBMET02686 0.064 0.04 DBMET02687 0.059 0.046 DBMET02685 0.059 0.046 DBMET02684 | DBMET02687 | |
| 0.044 | 0.03 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.031 DB00327 0.042 0.032 DBMET02685 0.042 0.032 DBMET02684 | ||
| 0.063 | 0.05 | 0.063 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.2 | 0.188 | 0.302 | Sodium/bile acid cotransporter inhibitor | 0.261 0.117 DB00327 0.291 0.088 DBMET02686 0.291 0.088 DBMET02687 0.302 0.077 DBMET02685 0.302 0.077 DBMET02684 0.2 0.188 DBMET02728 0.209 0.176 DBMET02727 0.209 0.176 DBMET02725 | DBMET02684 | |
| 0.065 | 0.058 | 0.065 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.05 | 0.043 | 0.05 | Acetylcholine muscarinic agonist | 0.05 0.044 DBMET02686 0.05 0.044 DBMET02687 0.049 0.045 DBMET02685 0.049 0.045 DBMET02684 | ||
| 0.021 | 0.015 | 0.036 | Nociceptin (N/OFQ) receptor agonist | 0.035 0.009 DB00327 0.024 0.013 DBMET00420 0.02 0.015 DBMET02686 0.02 0.015 DBMET02687 0.036 0.008 DBMET02685 0.036 0.008 DBMET02684 | DBMET02684 | |
| 0.037 | 0.035 | 0.041 | Acetylcholine M1 receptor agonist | 0.04 0.033 DBMET02686 0.04 0.033 DBMET02687 0.041 0.032 DBMET02685 0.041 0.032 DBMET02684 | DBMET02684 | |
| 0.054 | 0.052 | 0.068 | Lipocortins synthesis agonist | 0.058 0.04 DB00327 0.054 0.051 DBMET00420 0.056 0.044 DBMET02686 0.056 0.044 DBMET02687 0.058 0.041 DBMET02685 0.058 0.041 DBMET02684 0.068 0.023 DBMET02723 0.063 0.03 DBMET02728 0.064 0.029 DBMET02726 0.064 0.028 DBMET02727 0.064 0.029 DBMET02724 0.064 0.028 DBMET02725 | DBMET02723 | |
| 0.232 | 0.234 | 0.511 | Apoptosis agonist | 0.384 0.122 DBMET02686 0.384 0.122 DBMET02687 0.361 0.133 DBMET02685 0.361 0.133 DBMET02684 0.453 0.09 DBMET02723 0.487 0.078 DBMET02728 0.511 0.071 DBMET02726 0.479 0.081 DBMET02727 0.511 0.071 DBMET02724 0.479 0.081 DBMET02725 | DBMET02724 | |
| 0.023 | 0.027 | 0.028 | RNA-directed RNA polymerase stimulant | 0.026 0.024 DB00327 0.027 0.023 DBMET02686 0.027 0.023 DBMET02687 0.028 0.022 DBMET02685 0.028 0.022 DBMET02684 | DBMET02684 | |
| 0.033 | 0.038 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.031 DB00327 0.036 0.029 DBMET00420 0.035 0.034 DBMET02685 0.035 0.034 DBMET02684 | DBMET00420 | |
| 0.022 | 0.033 | 0.033 | Acetylcholine M4 receptor agonist | 0.033 0.019 DBMET02686 0.033 0.019 DBMET02687 0.03 0.022 DBMET02685 0.03 0.022 DBMET02684 | DBMET02687 | |
| 0.023 | 0.035 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET00420 | DBMET00420 | |
| 0.138 | 0.151 | 0.214 | Aldehyde oxidase inhibitor | 0.198 0.105 DB00327 0.208 0.1 DBMET02686 0.208 0.1 DBMET02687 0.214 0.097 DBMET02685 0.214 0.097 DBMET02684 | DBMET02684 | |
| 0.048 | 0.064 | 0.079 | NMDA 2C receptor antagonist | 0.079 0.026 DB00327 0.064 0.039 DBMET02685 0.064 0.039 DBMET02684 | DB00327 | |
| 0.15 | 0.166 | 0.631 | Antioxidant | 0.23 0.095 DB00327 0.179 0.133 DBMET00420 0.331 0.052 DBMET02686 0.331 0.052 DBMET02687 0.382 0.038 DBMET02685 0.382 0.038 DBMET02684 0.543 0.016 DBMET02723 0.472 0.024 DBMET02728 0.631 0.009 DBMET02726 0.516 0.018 DBMET02727 0.631 0.009 DBMET02724 0.516 0.018 DBMET02725 | DBMET02724 | |
| 0.028 | 0.054 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.044 0.036 DBMET02685 0.044 0.036 DBMET02684 | DBMET02684 | |
| 0.025 | 0.059 | 0.032 | Tubulin agonist | 0.032 0.031 DBMET02686 0.032 0.031 DBMET02687 0.032 0.03 DBMET02685 0.032 0.03 DBMET02684 | DBMET02684 | |
| 0.034 | 0.069 | 0.052 | Aromatase inhibitor | 0.052 0.047 DBMET00420 | DBMET00420 | |
| 0.011 | 0.046 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 DB00327 0.029 0.024 DBMET02685 0.029 0.024 DBMET02684 | DB00327 | |
| 0.184 | 0.223 | 0.479 | Histamine release inhibitor | 0.302 0.122 DBMET02686 0.302 0.122 DBMET02687 0.268 0.143 DBMET02685 0.268 0.143 DBMET02684 0.376 0.088 DBMET02723 0.479 0.037 DBMET02728 0.468 0.042 DBMET02726 0.46 0.045 DBMET02727 0.468 0.042 DBMET02724 0.46 0.045 DBMET02725 | DBMET02728 | |
| 0.056 | 0.096 | 0.124 | Glycine receptor agonist | 0.069 0.057 DB00327 0.112 0.015 DBMET02686 0.112 0.015 DBMET02687 0.124 0.011 DBMET02685 0.124 0.011 DBMET02684 0.104 0.019 DBMET02728 0.09 0.028 DBMET02726 0.115 0.014 DBMET02727 0.09 0.028 DBMET02724 0.115 0.014 DBMET02725 | DBMET02684 | |
| 0.047 | 0.088 | 0.189 | Antineoplastic antibiotic | 0.086 0.053 DBMET02686 0.086 0.053 DBMET02687 0.093 0.049 DBMET02685 0.093 0.049 DBMET02684 0.168 0.027 DBMET02723 0.164 0.028 DBMET02728 0.189 0.023 DBMET02726 0.174 0.026 DBMET02727 0.189 0.023 DBMET02724 0.174 0.026 DBMET02725 | DBMET02724 | |
| 0.123 | 0.165 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.138 0.081 DB00327 0.133 0.105 DBMET02686 0.133 0.105 DBMET02687 0.142 0.065 DBMET02685 0.142 0.065 DBMET02684 0.131 0.116 DBMET02723 0.13 0.12 DBMET02728 0.131 0.115 DBMET02726 0.139 0.076 DBMET02727 0.131 0.115 DBMET02724 0.139 0.076 DBMET02725 | DBMET02684 | |
| 0.023 | 0.07 | 0.049 | Estrogen agonist | 0.049 0.036 DB00327 0.049 0.036 DBMET02685 0.049 0.036 DBMET02684 0.046 0.038 DBMET02723 0.047 0.037 DBMET02727 0.047 0.037 DBMET02725 | DBMET02684 | |
| 0.06 | 0.117 | 0.109 | Bronchodilator | 0.109 0.053 DBMET02686 0.109 0.053 DBMET02687 | DBMET02687 | |
| 0.07 | 0.127 | 0.103 | Cystathionine beta-synthase inhibitor | 0.103 0.073 DB00327 | DB00327 | |
| 0.139 | 0.2 | 0.609 | Hypoglycemic | 0.189 0.123 DB00327 0.258 0.072 DBMET02686 0.258 0.072 DBMET02687 0.302 0.052 DBMET02685 0.302 0.052 DBMET02684 0.568 0.01 DBMET02723 0.486 0.016 DBMET02728 0.609 0.008 DBMET02726 0.528 0.013 DBMET02727 0.609 0.008 DBMET02724 0.528 0.013 DBMET02725 | DBMET02724 | |
| 0.172 | 0.243 | 0.383 | Interleukin 2 agonist | 0.234 0.137 DB00327 0.212 0.169 DBMET02686 0.212 0.169 DBMET02687 0.243 0.127 DBMET02685 0.243 0.127 DBMET02684 0.383 0.033 DBMET02723 0.356 0.043 DBMET02728 0.376 0.035 DBMET02726 0.376 0.035 DBMET02727 0.376 0.035 DBMET02724 0.376 0.035 DBMET02725 | DBMET02723 | |
| 0.103 | 0.178 | 0.176 | Melanin inhibitor | 0.133 0.108 DB00327 0.129 0.116 DBMET00420 0.133 0.108 DBMET02685 0.133 0.108 DBMET02684 0.168 0.061 DBMET02723 0.159 0.07 DBMET02728 0.155 0.075 DBMET02726 0.176 0.055 DBMET02727 0.155 0.075 DBMET02724 0.176 0.055 DBMET02725 | DBMET02725 | |
| 0.013 | 0.096 | 0.056 | 5 Hydroxytryptamine 2C agonist | 0.056 0.023 DBMET00420 | DBMET00420 | |
| 0.07 | 0.156 | 0.114 | Microtubule formation inhibitor | 0.098 0.095 DBMET02686 0.098 0.095 DBMET02687 0.114 0.068 DBMET02728 0.098 0.095 DBMET02727 0.098 0.095 DBMET02725 | DBMET02728 | |
| 0.049 | 0.136 | 0.126 | Glycine receptor antagonist | 0.086 0.047 DBMET02686 0.086 0.047 DBMET02687 0.103 0.03 DBMET02685 0.103 0.03 DBMET02684 0.103 0.03 DBMET02723 0.102 0.031 DBMET02728 0.126 0.015 DBMET02726 0.119 0.019 DBMET02727 0.126 0.015 DBMET02724 0.119 0.019 DBMET02725 | DBMET02724 | |
| 0.015 | 0.107 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DB00327 | DB00327 | |
| 0.036 | 0.132 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.078 0.052 DBMET02685 0.078 0.052 DBMET02684 0.1 0.032 DBMET02723 0.089 0.042 DBMET02728 0.098 0.034 DBMET02726 0.106 0.026 DBMET02727 0.098 0.034 DBMET02724 0.106 0.026 DBMET02725 | DBMET02725 | |
| 0.108 | 0.211 | 0.552 | Free radical scavenger | 0.194 0.103 DB00327 0.264 0.063 DBMET02686 0.264 0.063 DBMET02687 0.336 0.042 DBMET02685 0.336 0.042 DBMET02684 0.476 0.018 DBMET02723 0.385 0.032 DBMET02728 0.552 0.012 DBMET02726 0.434 0.024 DBMET02727 0.552 0.012 DBMET02724 0.434 0.024 DBMET02725 | DBMET02724 | |
| 0.022 | 0.131 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.082 0.019 DBMET02723 0.09 0.016 DBMET02728 0.08 0.019 DBMET02726 0.091 0.015 DBMET02727 0.08 0.019 DBMET02724 0.091 0.015 DBMET02725 | DBMET02725 | |
| 0.085 | 0.195 | 0.126 | Arachidonic acid antagonist | 0.126 0.118 DB00327 | DB00327 | |
| 0.057 | 0.184 | 0.182 | Alkylator | 0.119 0.069 DBMET02723 0.166 0.039 DBMET02728 0.122 0.066 DBMET02726 0.182 0.032 DBMET02727 0.122 0.066 DBMET02724 0.182 0.032 DBMET02725 | DBMET02725 | |
| 0.053 | 0.18 | 0.09 | Anabolic | 0.09 0.079 DBMET02685 0.09 0.079 DBMET02684 | DBMET02684 | |
| 0.047 | 0.178 | 0.125 | Creatine kinase inhibitor | 0.124 0.038 DB00327 0.125 0.037 DBMET02685 0.125 0.037 DBMET02684 | DBMET02684 | |
| 0.085 | 0.217 | 0.142 | Growth hormone agonist | 0.126 0.111 DBMET02686 0.126 0.111 DBMET02687 0.142 0.094 DBMET02685 0.142 0.094 DBMET02684 | DBMET02684 | |
| 0.027 | 0.161 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.064 0.02 DBMET02723 0.066 0.019 DBMET02728 0.067 0.018 DBMET02726 0.064 0.02 DBMET02727 0.067 0.018 DBMET02724 0.064 0.02 DBMET02725 | DBMET02724 | |
| 0.06 | 0.2 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.058 DB00327 0.079 0.067 DBMET02685 0.079 0.067 DBMET02684 | DB00327 | |
| 0.018 | 0.162 | 0.063 | NMDA 2 receptor antagonist | 0.063 0.059 DBMET02685 0.063 0.059 DBMET02684 | DBMET02684 | |
| 0.126 | 0.289 | 0.314 | Vasodilator, coronary | 0.25 0.135 DBMET02723 0.314 0.077 DBMET02728 0.252 0.133 DBMET02726 0.24 0.144 DBMET02727 0.252 0.133 DBMET02724 0.24 0.144 DBMET02725 | DBMET02728 | |
| 0.086 | 0.25 | 0.477 | Immunostimulant | 0.202 0.119 DBMET02686 0.202 0.119 DBMET02687 0.261 0.092 DBMET02685 0.261 0.092 DBMET02684 0.424 0.043 DBMET02723 0.434 0.041 DBMET02728 0.477 0.032 DBMET02726 0.474 0.033 DBMET02727 0.477 0.032 DBMET02724 0.474 0.033 DBMET02725 | DBMET02724 | |
| 0.087 | 0.252 | 0.171 | Interferon gamma antagonist | 0.171 0.056 DBMET02723 0.154 0.073 DBMET02728 0.161 0.066 DBMET02726 0.16 0.066 DBMET02727 0.161 0.066 DBMET02724 0.16 0.066 DBMET02725 | DBMET02723 | |
| 0.012 | 0.179 | 0.047 | Dopamine D5 agonist | 0.047 0.02 DBMET00420 | DBMET00420 | |
| 0.05 | 0.224 | 0.099 | Multidrug resistance-associated protein 1 inhibitor | 0.099 0.079 DBMET02728 | DBMET02728 | |
| 0.05 | 0.23 | 0.25 | Lipid peroxidase inhibitor | 0.121 0.092 DB00327 0.126 0.088 DBMET02686 0.126 0.088 DBMET02687 0.178 0.051 DBMET02685 0.178 0.051 DBMET02684 0.21 0.038 DBMET02723 0.186 0.048 DBMET02728 0.25 0.027 DBMET02726 0.224 0.033 DBMET02727 0.25 0.027 DBMET02724 0.224 0.033 DBMET02725 | DBMET02724 | |
| 0.027 | 0.211 | 0.1 | Androgen antagonist | 0.1 0.047 DBMET02685 0.1 0.047 DBMET02684 | DBMET02684 | |
| 0.018 | 0.204 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET02726 0.041 0.04 DBMET02724 | DBMET02724 | |
| 0.131 | 0.323 | 0.386 | Apoptosis antagonist | 0.254 0.124 DBMET02686 0.254 0.124 DBMET02687 0.275 0.104 DBMET02685 0.275 0.104 DBMET02684 0.332 0.065 DBMET02723 0.348 0.057 DBMET02728 0.386 0.042 DBMET02726 0.368 0.048 DBMET02727 0.386 0.042 DBMET02724 0.368 0.048 DBMET02725 | DBMET02724 | |
| 0.095 | 0.292 | 0.182 | Cyclic AMP phosphodiesterase inhibitor | 0.182 0.109 DBMET02723 0.168 0.125 DBMET02726 0.168 0.125 DBMET02724 | DBMET02723 | |
| 0.043 | 0.263 | 0.162 | DNA polymerase I inhibitor | 0.139 0.056 DBMET02686 0.139 0.056 DBMET02687 0.157 0.046 DBMET02685 0.157 0.046 DBMET02684 0.102 0.084 DBMET02723 0.094 0.093 DBMET02728 0.162 0.043 DBMET02726 0.105 0.081 DBMET02727 0.162 0.043 DBMET02724 0.105 0.081 DBMET02725 | DBMET02724 | |
| 0.009 | 0.231 | 0.184 | Cathepsin L2 inhibitor | 0.153 0.005 DBMET02728 0.184 0.005 DBMET02727 0.184 0.005 DBMET02725 | DBMET02725 | |
| 0.044 | 0.276 | 0.14 | Adenylate cyclase inhibitor | 0.094 0.09 DB00327 0.14 0.052 DBMET02685 0.14 0.052 DBMET02684 | DBMET02684 | |
| 0.014 | 0.249 | 0.027 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET02723 0.027 0.016 DBMET02728 0.026 0.02 DBMET02726 0.026 0.019 DBMET02727 0.026 0.02 DBMET02724 0.026 0.019 DBMET02725 | DBMET02728 | |
| 0.003 | 0.239 | 0.045 | Arginase inhibitor | 0.034 0.028 DBMET02723 0.045 0.018 DBMET02726 0.045 0.018 DBMET02724 | DBMET02724 | |
| 0.008 | 0.266 | 0.04 | Protein 30S ribosomal subunit inhibitor | 0.028 0.013 DBMET02723 0.031 0.012 DBMET02728 0.028 0.014 DBMET02726 0.04 0.01 DBMET02727 0.028 0.014 DBMET02724 0.04 0.01 DBMET02725 | DBMET02725 | |
| 0.05 | 0.319 | 0.172 | Diuretic | 0.154 0.074 DBMET02723 0.172 0.059 DBMET02726 0.138 0.087 DBMET02727 0.172 0.059 DBMET02724 0.138 0.087 DBMET02725 | DBMET02724 | |
| 0.014 | 0.298 | 0.063 | Alpha-mannosidase inhibitor | 0.051 0.043 DBMET02723 0.056 0.032 DBMET02728 0.063 0.023 DBMET02726 0.058 0.029 DBMET02727 0.063 0.023 DBMET02724 0.058 0.029 DBMET02725 | DBMET02724 | |
| 0.063 | 0.349 | 0.144 | Non-steroidal antiinflammatory agent | 0.144 0.123 DBMET02728 | DBMET02728 | |
| 0.063 | 0.351 | 0.123 | Adenylate cyclase stimulant | 0.123 0.118 DBMET02685 0.123 0.118 DBMET02684 | DBMET02684 | |
| 0.015 | 0.305 | 0.066 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET02723 0.062 0.008 DBMET02728 0.059 0.009 DBMET02726 0.066 0.007 DBMET02727 0.059 0.009 DBMET02724 0.066 0.007 DBMET02725 | DBMET02725 | |
| 0.085 | 0.385 | 0.535 | Antithrombotic | 0.472 0.033 DBMET02723 0.491 0.03 DBMET02728 0.482 0.032 DBMET02726 0.535 0.024 DBMET02727 0.482 0.032 DBMET02724 0.535 0.024 DBMET02725 | DBMET02725 | |
| 0.018 | 0.345 | 0.086 | Topoisomerase II alpha inhibitor | 0.086 0.049 DBMET02728 0.08 0.053 DBMET02727 0.08 0.053 DBMET02725 | DBMET02728 | |
| 0.029 | 0.356 | 0.167 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET02723 0.146 0.031 DBMET02728 0.134 0.039 DBMET02726 0.167 0.019 DBMET02727 0.134 0.039 DBMET02724 0.167 0.019 DBMET02725 | DBMET02725 | |
| 0.024 | 0.366 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.09 0.057 DBMET02723 0.092 0.052 DBMET02728 0.092 0.052 DBMET02726 0.086 0.064 DBMET02727 0.092 0.052 DBMET02724 0.086 0.064 DBMET02725 | DBMET02724 | |
| 0.036 | 0.383 | 0.47 | Angiogenesis stimulant | 0.462 0.014 DBMET02723 0.446 0.016 DBMET02728 0.47 0.014 DBMET02726 0.467 0.014 DBMET02727 0.47 0.014 DBMET02724 0.467 0.014 DBMET02725 | DBMET02724 | |
| 0.048 | 0.398 | 0.225 | Interleukin agonist | 0.193 0.128 DBMET02723 0.194 0.127 DBMET02728 0.178 0.141 DBMET02726 0.225 0.099 DBMET02727 0.178 0.141 DBMET02724 0.225 0.099 DBMET02725 | DBMET02725 | |
| 0.008 | 0.374 | 0.048 | Mannosidase inhibitor | 0.048 0.027 DBMET02726 0.043 0.035 DBMET02727 0.048 0.027 DBMET02724 0.043 0.035 DBMET02725 | DBMET02724 | |
| 0.043 | 0.409 | 0.192 | Antiamyloidogenic | 0.192 0.105 DBMET02728 0.172 0.121 DBMET02727 0.172 0.121 DBMET02725 | DBMET02728 | |
| 0.067 | 0.451 | 0.32 | Cholesterol antagonist | 0.243 0.13 DBMET02723 0.284 0.101 DBMET02728 0.317 0.081 DBMET02726 0.32 0.079 DBMET02727 0.317 0.081 DBMET02724 0.32 0.079 DBMET02725 | DBMET02725 | |
| 0.021 | 0.405 | 0.137 | Topoisomerase II inhibitor | 0.114 0.073 DBMET02723 0.13 0.06 DBMET02728 0.129 0.06 DBMET02726 0.137 0.056 DBMET02727 0.129 0.06 DBMET02724 0.137 0.056 DBMET02725 | DBMET02725 | |
| 0.018 | 0.403 | 0.114 | Topoisomerase I inhibitor | 0.106 0.065 DBMET02723 0.11 0.062 DBMET02728 0.114 0.06 DBMET02726 0.108 0.064 DBMET02727 0.114 0.06 DBMET02724 0.108 0.064 DBMET02725 | DBMET02724 | |
| 0.017 | 0.408 | 0.118 | M18 aspartyl aminopeptidase inhibitor | 0.1 0.092 DBMET02686 0.1 0.092 DBMET02687 0.118 0.072 DBMET02685 0.118 0.072 DBMET02684 | DBMET02684 | |
| 0.003 | 0.448 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET02726 0.026 0.019 DBMET02724 | DBMET02724 | |
| 0.037 | 0.482 | 0.261 | Platelet adhesion inhibitor | 0.227 0.058 DBMET02723 0.261 0.046 DBMET02728 0.243 0.052 DBMET02726 0.255 0.048 DBMET02727 0.243 0.052 DBMET02724 0.255 0.048 DBMET02725 | DBMET02728 | |
| 0.041 | 0.492 | 0.269 | DNA synthesis inhibitor | 0.226 0.087 DBMET02723 0.214 0.103 DBMET02728 0.226 0.087 DBMET02726 0.269 0.056 DBMET02727 0.226 0.087 DBMET02724 0.269 0.056 DBMET02725 | DBMET02725 | |
| 0.026 | 0.488 | 0.115 | Amylase inhibitor | 0.109 0.089 DBMET02728 0.099 0.098 DBMET02726 0.115 0.085 DBMET02727 0.099 0.098 DBMET02724 0.115 0.085 DBMET02725 | DBMET02725 | |
| 0.079 | 0.548 | 0.134 | CC chemokine 6 receptor antagonist | 0.13 0.071 DBMET02723 0.13 0.072 DBMET02728 0.128 0.078 DBMET02726 0.134 0.056 DBMET02727 0.128 0.078 DBMET02724 0.134 0.056 DBMET02725 | DBMET02725 | |
| 0.059 | 0.53 | 0.321 | Immunomodulator | 0.321 0.071 DBMET02723 0.223 0.139 DBMET02728 0.318 0.072 DBMET02726 0.24 0.123 DBMET02727 0.318 0.072 DBMET02724 0.24 0.123 DBMET02725 | DBMET02723 | |
| 0.033 | 0.512 | 0.097 | Transcription factor NF kappa B stimulant | 0.089 0.053 DBMET02723 0.097 0.041 DBMET02728 0.091 0.049 DBMET02726 0.097 0.041 DBMET02727 0.091 0.049 DBMET02724 0.097 0.041 DBMET02725 | DBMET02725 | |
| 0.082 | 0.587 | 0.352 | Peptidyltransferase inhibitor | 0.321 0.018 DBMET02723 0.339 0.014 DBMET02728 0.329 0.016 DBMET02726 0.352 0.012 DBMET02727 0.329 0.016 DBMET02724 0.352 0.012 DBMET02725 | DBMET02725 | |
| 0.004 | 0.513 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.018 DBMET02726 0.025 0.018 DBMET02724 | DBMET02724 | |
| 0.04 | 0.575 | 0.342 | Antiobesity | 0.222 0.185 DBMET02685 0.222 0.185 DBMET02684 0.342 0.091 DBMET02726 0.342 0.091 DBMET02724 | DBMET02724 | |
| 0.032 | 0.582 | 0.176 | ATPase inhibitor | 0.143 0.114 DBMET02728 0.176 0.063 DBMET02726 0.138 0.124 DBMET02727 0.176 0.063 DBMET02724 0.138 0.124 DBMET02725 | DBMET02724 | |
| 0.02 | 0.576 | 0.201 | Platelet antagonist | 0.163 0.131 DBMET02723 0.168 0.127 DBMET02728 0.201 0.1 DBMET02726 0.201 0.1 DBMET02724 | DBMET02724 | |
| 0.025 | 0.583 | 0.182 | Hemostatic | 0.163 0.054 DBMET02723 0.13 0.096 DBMET02728 0.154 0.063 DBMET02726 0.182 0.041 DBMET02727 0.154 0.063 DBMET02724 0.182 0.041 DBMET02725 | DBMET02725 | |
| 0.018 | 0.672 | 0.265 | Insulin secretagoues | 0.235 0.023 DBMET02723 0.142 0.083 DBMET02728 0.265 0.017 DBMET02726 0.15 0.075 DBMET02727 0.265 0.017 DBMET02724 0.15 0.075 DBMET02725 | DBMET02724 | |
| 0.031 | 0.721 | 0.658 | Cyclophilin D inhibitor | 0.593 0.029 DBMET02723 0.46 0.063 DBMET02728 0.658 0.019 DBMET02726 0.507 0.048 DBMET02727 0.658 0.019 DBMET02724 0.507 0.048 DBMET02725 | DBMET02724 | |
| 0.016 | 0.752 | 0.544 | Antibacterial | 0.439 0.061 DBMET02723 0.489 0.044 DBMET02728 0.467 0.051 DBMET02726 0.544 0.03 DBMET02727 0.467 0.051 DBMET02724 0.544 0.03 DBMET02725 | DBMET02725 | |
| 0.012 | 0.756 | 0.117 | Cell adhesion inhibitor | 0.117 0.067 DBMET02723 0.116 0.068 DBMET02726 0.116 0.068 DBMET02724 | DBMET02723 | |
| 0.008 | 0.788 | 0.058 | Cathepsin F inhibitor | 0.056 0.008 DBMET02728 0.058 0.006 DBMET02727 0.058 0.006 DBMET02725 | DBMET02725 | |
| 0.004 | 0.817 | 0.231 | Selectin antagonist | 0.212 0.01 DBMET02723 0.207 0.01 DBMET02728 0.231 0.009 DBMET02726 0.231 0.009 DBMET02727 0.231 0.009 DBMET02724 0.231 0.009 DBMET02725 | DBMET02725 | |
| 0.006 | 0.897 | 0.168 | Thrombolytic | 0.139 0.09 DBMET02723 0.152 0.08 DBMET02728 0.161 0.074 DBMET02726 0.168 0.069 DBMET02727 0.161 0.074 DBMET02724 0.168 0.069 DBMET02725 | DBMET02725 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |